Unal, C. Et Al. 2023. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. ONCOLOGIST , vol.28 , 875-884.

Unal, C., Azizy, A., Karabulut, S., Tastekin, D., AKYILDIZ, A., YAŞAR, S., ... YALÇIN, Ş.(2023). Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. ONCOLOGIST , vol.28, 875-884.

Unal, Caglar Et Al. "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group," ONCOLOGIST , vol.28, 875-884, 2023

Unal, Caglar Et Al. "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group." ONCOLOGIST , vol.28, pp.875-884, 2023

Unal, C. Et Al. (2023) . "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group." ONCOLOGIST , vol.28, pp.875-884.

@article{article, author={Caglar Unal Et Al. }, title={Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group}, journal={ONCOLOGIST}, year=2023, pages={875-884} }